Skip to main content
. 2023 Aug 21;13(3):e12281. doi: 10.1002/pul2.12281

Figure 3.

Figure 3

Kaplan–Meier curve of survival after PAH diagnosis and PVDOMICS enrollment in AVR‐responders versus non‐AVR responders' IPAH patients (a and b, respectively), and AVR‐responders versus non‐AVR responders' CTD‐PAH patients (c and d, respectively). IPAH, idiopathic pulmonary arterial hypertension.